Numis Securities reaffirmed their buy rating on shares of Horizon Discovery Group (LON:HZD) in a research report released on Thursday. The firm currently has a GBX 300 ($4.21) target price on the stock.
Shares of Horizon Discovery Group (LON:HZD) opened at GBX 192.50 ($2.70) on Thursday. The stock has a market cap of $286.99 and a price-to-earnings ratio of -1,375.00. Horizon Discovery Group has a fifty-two week low of GBX 160 ($2.25) and a fifty-two week high of GBX 294 ($4.13).
TRADEMARK VIOLATION WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/05/horizon-discovery-group-hzd-stock-rating-reaffirmed-by-numis-securities.html.
About Horizon Discovery Group
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer.
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.